Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Healthy Infants
Clinical trial NCT01098474 · COMPLETED
Trial details
- NCT number
- NCT01098474
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-07
- Primary completion
- 2011-04-30
- Enrollment
- 301
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.